Spyre Therapeutics, Inc. (SYRE)
74.32
+2.40
(+3.34%)
USD |
NASDAQ |
May 21, 16:00
74.32
0.00 (0.00%)
After-Hours: 19:59
Spyre Therapeutics Accounts Payable (Quarterly) : 5.692M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 3.642M |
| Revolution Medicines, Inc. | 80.54M |
| Apellis Pharmaceuticals, Inc. | 49.05M |
| Replimune Group, Inc. | 5.647M |
| Savara, Inc. | 4.496M |